Addex Therapeutics (ADXN) Interest Coverage Ratio (2019 - 2026)
Addex Therapeutics (ADXN) posted Interest Coverage Ratio of 0.0 for Q1 2026, down 100.0% sequentially from 852.11 in Q3 2025, and down 31.81% YoY from 0.0 in Q1 2025.
Addex Therapeutics (ADXN) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Addex Therapeutics has reported Interest Coverage Ratio for 8 years, with the latest figure at 0.0 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 31.81% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 47.34% YoY) and the FY2025 annual result came in at 181.04, up 76.69% from the prior year.
- Interest Coverage Ratio fell to 0.0 in Q1 2026 per ADXN's latest filing, from 852.11 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 852.11 in Q3 2025 and troughed at 1040.88 in Q2 2024.
- A 5-year average of 47.95 and a median of 0.0 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio plunged 37134.91% in 2024, then surged 1059046697.32% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 61.54 in 2022, then surged by 100.0% to 0.0 in 2023, then sank by 110.48% to 0.0 in 2024, then jumped by 239179060.0% to 852.11 in 2025, then sank by 100.0% to 0.0 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.0, 852.11, and 125.75 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 180.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Sep 30, 2025 | 852.11 |
| Jun 30, 2025 | 125.75 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -1,040.88 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -2.80 |
| Mar 31, 2023 | 39.62 |
| Dec 31, 2022 | -61.54 |
| Sep 30, 2022 | 652.72 |
| Jun 30, 2022 | -54.88 |
| Mar 31, 2022 | 257.10 |
| Dec 31, 2021 | -132.89 |
| Sep 30, 2021 | 36.73 |
| Jun 30, 2021 | -196.46 |
| Mar 31, 2021 | 151.79 |